NEW YORK (GenomeWeb) – Abbott said today that it has filed a complaint in the Delaware Chancery Court to terminate its proposed $5.8 billion acquisition of Alere.

In a statement, Abbott said that it wants out of the deal because of "the substantial loss in Alere's value following the merger agreement," and what it described as adverse events that materially change Alere's long-term prospects.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.